Business
Announcement on Subsidiary Obtaining FDA New Drug Approval for Fosfomycin for Injection
Announcement on Subsidiary Obtaining FDA New Drug Approval for Fosfomycin for Injection
About this update from Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class A
Announcement on Subsidiary Obtaining FDA New Drug Approval for Fosfomycin for InjectionThe abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment